Population
Saccharomyces cerevisiae (yeast) strains (wild-type and MYO2DN)
Comparison
Overexpression of the carboxyl-terminal-tail… vs Yeast cells transformed with the GAL1 vector alone
Design
Preclinical
Authors
Loading...
Yeast myosin findings offer no immediate clinical implications; leaves open extension to mammalian cardiovascular cell biology.
The carboxyl-terminal tail of the yeast class V myosin Myo2p is sufficient for localization to sites of polarized cell growth and its overexpression competitively inhibits endogenous Myo2p localization.
Reck‐Peterson et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: